TELO2-related intellectual disability-neurodevelopmental disorder


caudal regression-sirenomelia spectrum

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:ThingWithTaxon biolink:BiologicalEntity biolink:NamedThing biolink:Entity


spondylocostal dysostosis-anal and genitourinary malformations syndrome


deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome


hypospadias-intellectual disability, Goldblatt type syndrome


lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome


lethal hemolytic anemia-genital anomalies syndrome


Turner syndrome due to structural X chromosome anomalies


ectopia lentis 2, isolated, autosomal recessive


Stage II Uterine Corpus Leiomyosarcoma AJCC v8


tissue-type plasminogen activator N-glycosylated 79 (human)


Polymorphic lymphoproliferative disorder following transplant


Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder


Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder


tyrosine-protein phosphatase non-receptor type 11 phosphorylated 1 (human)


Grade 2 Postoperative Hemorrhage, CTCAE

biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:ThingWithTaxon biolink:BiologicalEntity biolink:NamedThing biolink:Entity


congenital hypotrichosis with juvenile macular dystrophy


poly [ADP-ribose] polymerase 2 ADP-ribosylglutamate form (human)


protein kinase C epsilon type isoform 1 (human)


Pathologic Stage IIIA Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


Clinical Stage IVB Gastric Cancer AJCC v8


Pathologic Stage IIIB Gastric Cancer AJCC v8


Pathologic Stage IIA Gastric Cancer AJCC v8


Clinical Stage III Gastric Cancer AJCC v8


Pathologic Stage IIIC Gastric Cancer AJCC v8


Pathologic Stage IV Gastric Cancer AJCC v8


Clinical Stage IIA Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8


Clinical Stage IVA Gastric Cancer AJCC v8


Pathologic Stage IIB Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8


Pathologic Stage II Gastric Cancer AJCC v8


Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage


Pathologic Stage IA Gastric Cancer AJCC v8


Clinical Stage II Gastric Cancer AJCC v8


Clinical Stage IIB Gastric Cancer AJCC v8


Clinical Stage IV Gastric Cancer AJCC v8


Gastric Cancer by AJCC v8 Pathologic Stage


Pathologic Stage I Gastric Cancer AJCC v8


Pathologic Stage III Gastric Cancer AJCC v8


Pathologic Stage IB Gastric Cancer AJCC v8


Gastric Cancer by AJCC v8 Clinical Stage


Pathologic Stage 0 Gastric Cancer AJCC v8


Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


ubiquitin carboxyl-terminal hydrolase isozyme L3 isoform 1 (human)


tyrosine-protein kinase Fer isoform 1 (human)


tyrosine-protein kinase Fer isoform 3 (human)


tyrosine-protein kinase Fer isoform h2 (human)


Esophageal Atresia/Tracheoesophageal Fistula Type C


H-type congenital tracheoesophageal fistula


diamine acetyltransferase 1 isoform 1 (human)


eIF-2-alpha kinase GCN2 isoform h2 (human)


ribosomal protein S6 kinase beta-1 isoform 1 phosphorylated 1 (human)


vertebral, cardiac, renal, and limb defects syndrome 3


congenital vertebral-cardiac-renal anomalies syndrome


vertebral, cardiac, renal, and limb defects syndrome 1


vertebral, cardiac, renal, and limb defects syndrome 2


cyclin-dependent kinase 9 phosphorylated 1 (human)


tumor necrosis factor isoform 1 myristoylated 1 (human)


Histoplasma capsulatum infectious disease


Adverse Event Attributed to Investigational New Drug


beta-1 adrenergic receptor isoform 1 (mouse)


beta-1 adrenergic receptor isoform 1 (rat)


beta-3 adrenergic receptor isoform A (mouse)


beta-2 adrenergic receptor phosphoserine form (human)


beta-1 adrenergic receptor phosphorylated 1 (human)


beta-2 adrenergic receptor ubiquitinated form (human)


beta-2 adrenergic receptor phosphorylated 1 (human)


beta-3 adrenergic receptor isoform B (mouse)


beta-3 adrenergic receptor isoform 1 (rat)


Esophageal squamous cell carcinoma recurrent


vasoactive intestinal polypeptide receptor 1 isoform Long (human)


vitamin K-dependent protein C N-glycosylated 3 (human)


Grade 1 Muscle Intra-Operative Injury, CTCAE


Closed fracture of mandible, multiple sites


Descending Colon Neuroendocrine Tumor G1


sodium- and chloride-dependent glycine transporter 2 isoform h1 (human)


alpha-2A adrenergic receptor isoform 1 (human)


alpha-2A adrenergic receptor isoform 1 (mouse)


prostate-specific antigen N-glycosylated 26 (human)


Grade 2 Liver Dysfunction or Failure by Clinical Classification, CTCAE


microtubule-associated protein tau isoform Tau-F phosphorylated 11 (human)


developmental and epileptic encephalopathy, 62


Benign Epithelial Melanoses of the Conjunctiva


immunoskeletal dysplasia with neurodevelopmental abnormalities


sodium channel subunit beta-1 isoform 1 (human)


tyrosine-protein kinase ZAP-70 isoform 1 phosphorylated 1 (human)


tyrosine-protein kinase ZAP-70 isoform 1 (human)


tyrosine-protein kinase ZAP-70 phosphorylated 2 (human)


tyrosine-protein kinase ZAP-70 phosphorylated 1 (human)


tyrosine-protein kinase ZAP-70 isoform h3 (human)


tyrosine-protein kinase ZAP-70 phosphorylated 3 (human)


tyrosine-protein kinase ZAP-70 isoform 2 (human)


Grade 5 Neck Infection NOS Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE


microtubule-associated protein tau isoform Tau-F phosphorylated 6 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3B (human)


prostaglandin E2 receptor EP3 subtype isoform h12 (human)


prostaglandin F2-alpha receptor isoform h7 (human)


prostaglandin D2 receptor isoform h2 (human)


prostaglandin D2 receptor isoform h1 (human)


prostaglandin F2-alpha receptor isoform h4 (human)


prostaglandin E2 receptor EP3 subtype isoform Alpha (mouse)


prostaglandin E2 receptor EP3 subtype isoform hEP3-IV (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3E2 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3E (human)


prostaglandin F2-alpha receptor isoform h3 (human)


prostaglandin E2 receptor EP1 subtype isoform 1 (rat)


prostaglandin E2 receptor EP3 subtype isoform Alpha (rat)


prostaglandin E2 receptor EP1 subtype isoform 1 (mouse)


prostaglandin E2 receptor EP3 subtype isoform hEP3A (human)


prostaglandin E2 receptor EP3 subtype isoform Beta (mouse)


thromboxane A2 receptor isoform h2 (human)


thromboxane A2 receptor isoform 1 (mouse)


prostaglandin F2-alpha receptor isoform h1 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3-V (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3-III (human)


prostaglandin F2-alpha receptor isoform h6 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3C (human)


prostaglandin E2 receptor EP1 subtype isoform r2 (rat)


prostaglandin E2 receptor EP3 subtype isoform hEP3G (human)


prostaglandin F2-alpha receptor isoform h5 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3D (human)


thromboxane A2 receptor isoform h1 (human)


prostaglandin E2 receptor EP3 subtype isoform hEP3F (human)


prostaglandin F2-alpha receptor isoform h2 (human)


prostaglandin E2 receptor EP3 subtype isoform Gamma (rat)


prostaglandin E2 receptor EP3 subtype isoform Beta (rat)


prostaglandin E2 receptor EP3 subtype isoform Gamma (mouse)


prostaglandin F2-alpha receptor isoform 1 (mouse)


Adenocarcinoma in multiple adenomatous polyps


Adenocarcinoma in adenomatous polyposis coli


sodium/myo-inositol cotransporter 2 isoform h1 (human)


Grade 2 Stomach Infection with Unknown Absolute Neutrophil Count, CTCAE


Epididymal Melanotic Neuroectodermal Tumor


serine/threonine-protein kinase Nek9, initiator methionine removed phosphorylated 3 (human)


Grade 4 Cecum Stricture or Stenosis, CTCAE


Grade 5 Cecum Stricture or Stenosis, CTCAE


Grade 3 Cecum Stricture or Stenosis, CTCAE


Grade 1 Cecum Stricture or Stenosis, CTCAE


Grade 2 Cecum Stricture or Stenosis, CTCAE


hypogonadism-mitral valve prolapse-intellectual disability syndrome


familial isolated deficiency of vitamin E


Drug-induced cutaneous lupus erythematosus


protein kinase C alpha type, initiator methionine removed phosphorylated 1 (human)


hematopoietic prostaglandin D synthase, initiator methionine removed form (human)


Childhood Clear Cell Sarcoma of Soft Parts


Metastatic Clear Cell Sarcoma of Soft Tissue


Advanced Clear Cell Sarcoma of Soft Tissue


Recurrent Clear Cell Sarcoma of Soft Tissue


Refractory Clear Cell Sarcoma of Soft Tissue


homeodomain-interacting protein kinase 2 isoform h1 (human)


homeodomain-interacting protein kinase 2


homeodomain-interacting protein kinase 2 isoform h2 (human)


homeodomain-interacting protein kinase 2 isoform h3 (human)


homeodomain-interacting protein kinase 2 phosphorylated form (human)


COG4-congenital disorder of glycosylation


primary cutaneous gamma/delta-positive T-cell lymphoma


succinate-semialdehyde dehydrogenase, mitochondrial isoform h1 (human)


fatty acid-binding protein 5 isoform 1 (human)


fatty acid-binding protein 5, initiator methionine removed form (human)


Grade 1 Carbon Monoxide Diffusing Capacity Decreased, CTCAE


Locally Advanced Unresectable Gastric Adenocarcinoma


Metastatic Unresectable Basal Cell Carcinoma


Locally Advanced Unresectable Esophageal Adenocarcinoma


Locally Advanced Unresectable Colorectal Adenocarcinoma


Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


Locally Advanced Unresectable Pancreatic Adenocarcinoma


Metastatic Unresectable Gastric Adenocarcinoma


Locally Advanced Unresectable Triple-Negative Breast Carcinoma


Locally Advanced Unresectable Colon Adenocarcinoma


Locally Advanced Unresectable Basal Cell Carcinoma


Locally Advanced Unresectable Prostate Adenocarcinoma


Locally Advanced Unresectable Breast Carcinoma


Unresectable Castration-Resistant Prostate Carcinoma


Locally Advanced Unresectable Renal Cell Carcinoma


Locally Advanced Unresectable HER2-Negative Breast Carcinoma


Locally Advanced Unresectable Cervical Adenocarcinoma


Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma


Locally Advanced Unresectable HER2-Positive Breast Carcinoma


Locally Advanced Unresectable Fallopian Tube Carcinoma


Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma


Locally Advanced Unresectable Prostate Carcinoma


Locally Advanced Unresectable Cervical Carcinoma


X-linked sideroblastic anemia with ataxia


Undifferentiated Juvenile Idiopathic Arthritis


Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage


Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Recurrent Metastatic Merkel Cell Carcinoma


Recurrent Metastatic Digestive System Carcinoma


Recurrent Metastatic Malignant Neoplasm in the Leptomeninges


Recurrent Metastatic Skin Squamous Cell Carcinoma


Grade 2 Sinus Intra-Operative Injury, CTCAE


nuclear receptor ROR-gamma isoform 1 (human)


nuclear receptor ROR-gamma isoform h2 (human)


Mitochondrially Inherited Nonsyndromic Sensorineural Deafness


Deafness due to Connexin 26 Gene Anomaly


autosomal recessive nonsyndromic hearing loss 1A


autosomal recessive nonsyndromic hearing loss 49


autosomal dominant nonsyndromic hearing loss 36


autosomal recessive nonsyndromic hearing loss 36


autosomal recessive nonsyndromic hearing loss 28


autosomal recessive nonsyndromic hearing loss 39


autosomal dominant nonsyndromic hearing loss 41


X-linked hereditary sensory and autonomic neuropathy with hearing loss


severe intellectual disability-progressive spastic diplegia syndrome


amyloid-beta precursor protein O-glycosylated 6 (human)


Grade 1 Intraoperative Venous Injury, CTCAE


Grade 2 Intraoperative Venous Injury, CTCAE


Grade 4 Intraoperative Venous Injury, CTCAE


Grade 3 Intraoperative Venous Injury, CTCAE


Grade 5 Intraoperative Venous Injury, CTCAE


Grade 1 Genitourinary Stoma Prolapse, CTCAE


Testicular Mixed Choriocarcinoma and Teratoma


B-cell antigen receptor complex-associated protein beta chain, signal peptide removed form (human)


B-cell antigen receptor complex-associated protein beta chain, signal peptide removed phosphorylated 1 (human)


hyperphosphatasia with intellectual disability syndrome 2


potassium voltage-gated channel subfamily D member 3 isoform 2 (human)


potassium voltage-gated channel subfamily D member 3 isoform 2 (mouse)


Grade 4 Trachea Infection Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE


Malignant nasopharyngeal neoplasm recurrent


superoxide dismutase [Mn], mitochondrial, transit peptide removed form (human)


interleukin-1 alpha isoform 1 myristoylated 2 (human)


interleukin-1 alpha isoform 1 myristoylated 1 (human)


interleukin-1 alpha isoform 1 cleaved 1 (human)


follicular dendritic cell sarcoma of mediastinum


vitamin K-dependent gamma-carboxylase isoform 1 (human)


Pancreatic Mucinous-Cystic Neoplasm, High Grade


Parenteral Nutrition - Associated Cholestasis


Grade 4 Intraoperative Musculoskeletal Injury, CTCAE


amyloidosis, primary localized cutaneous, 1


familial primary localized cutaneous amyloidosis


amyloidosis, primary localized cutaneous, 3


amyloidosis, primary localized cutaneous, 2


Stage IB Fallopian Tube Cancer AJCC v6 and v7


Grade 1 Abdominal Distension or Bloating, CTCAE


lutropin-choriogonadotropic hormone receptor isoform Long (human)


follicular atrophoderma-basal cell carcinoma


BMP receptor type-1B isoform 1 phosphorylated 1 (human)


sick sinus syndrome 2, autosomal dominant


potassium-transporting ATPase alpha chain 1, initiator methionine removed form (human)


congenital narrowing of cervical spinal canal


atrial natriuretic peptide receptor 2 isoform Long (human)


phosphoserine aminotransferase isoform 1 (human)


5-hydroxytryptamine receptor 3B isoform h2 (human)


5-hydroxytryptamine receptor 3B, signal peptide removed form (human)


5-hydroxytryptamine receptor 3B isoform h1 (human)


Refractory Vaginal Squamous Cell Carcinoma


dual specificity protein kinase TTK isoform h1 (human)


TTK activation loop and P+1 loop phosphorylated form (human)


TTK activation loop-phosphorylated form (human)


dual specificity protein kinase TTK isoform h2 (human)


dual specificity protein kinase TTK phosphorylated 1 (human)


2:1 Atrioventricular Block by ECG Finding


[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial


[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial isoform h1 (human)


[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial isoform 2 (human)


Myeloblasts 5-19 Percent of Peripheral Blood White Cells


Myeloblasts 10-19 Percent of Peripheral Blood White Cells


von Willebrand factor N-glycosylated 32 (human)


calcitonin gene-related peptide type 1 receptor


calcitonin gene-related peptide type 1 receptor, signal peptide removed form (human)


NAD-dependent protein deacylase sirtuin-5, mitochondrial isoform 1 (human)


cAMP-dependent protein kinase catalytic subunit alpha isoform 1 (cow)


cAMP-dependent protein kinase catalytic subunit alpha isoform 1, initiator methionine removed phosphorylated 1 (cow)


Prostate Stromal Proliferation of Uncertain Malignant Potential


Secondary malignant neoplasm of supraclavicular lymph nodes


Metastatic Malignant Neoplasm in the Regional Lymph Nodes


Breast Carcinoma Metastatic in the Lymph Nodes


Secondary malignant neoplasm of mediastinal lymph nodes


Prostate Carcinoma Metastatic in the Lymph Nodes


Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes


Dextro-Transposition of the Great Vessels with Intact Ventricular Septum


death-associated protein kinase 2 isoform 1 (human)


death-associated protein kinase 3 isoform h2 (human)


death-associated protein kinase 3 isoform 1 (human)


death-associated protein kinase 1 isoform h2 (human)


death-associated protein kinase 1 isoform h4 (human)


death-associated protein kinase 1 phosphorylated 1 (human)


death-associated protein kinase 2 isoform h2 (human)


death-associated protein kinase 1 isoform h3 (human)


death-associated protein kinase 1 isoform 1 (human)


death-associated protein kinase 3 phosphorylated 1 (human)


Grade 3 Neck Soft Tissue Necrosis, CTCAE


Grade 3 Peripheral Motor Nerve NOS Intra-Operative Injury, CTCAE


Central Nervous System Teratoma with Malignant Transformation


Sellar Teratoma with Malignant Transformation


DNA polymerase eta ubiquitinated 1 (human)


Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host Disease


Grade 1 Respiratory Tract Hemorrhage NOS, CTCAE


ephrin type-A receptor 1 isoform h2 (human)


ephrin type-A receptor 1 isoform h1 (human)


ephrin type-A receptor 1 isoform h3 (human)


ephrin type-A receptor 1, signal peptide removed form (human)


high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform hPDE9A2 (human)


NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2, initiator methionine removed form (human)


voltage-dependent L-type calcium channel subunit alpha-1C isoform h5 (human)


ACTH-independent macronodular adrenal hyperplasia 1


Cushing syndrome due to macronodular adrenal hyperplasia


ACTH-independent macronodular adrenal hyperplasia 2


von Willebrand factor N-glycosylated 9 (human)


tissue-type plasminogen activator N-glycosylated 24 (human)


small conductance calcium-activated potassium channel protein 1 isoform 2 (human)


calcium-activated calmodulin-binding potassium channel alpha subunit


intermediate conductance calcium-activated potassium channel protein 4 isoform 1 (human)


small conductance calcium-activated potassium channel protein 1


small conductance calcium-activated potassium channel protein 1 isoform h1 (human)


small conductance calcium-activated potassium channel protein 2 isoform 2 (human)


small conductance calcium-activated potassium channel protein 3 isoform 1 (human)


small conductance calcium-activated potassium channel protein 2 isoform 1 (human)


small conductance calcium-activated potassium channel protein 2


small conductance calcium-activated potassium channel protein 3


intermediate conductance calcium-activated potassium channel protein 4


small conductance calcium-activated potassium channel protein 3 sequence variant 1 (human)


small conductance calcium-activated potassium channel protein 3 isoform h2 (human)


small conductance calcium-activated potassium channel protein 3 isoform h3 (human)


microphthalmia, isolated, with coloboma 4


Stage IV Colorectal Neuroendocrine Tumor AJCC v8


Stage IV Colon Neuroendocrine Tumor AJCC v8


Stage IV Rectal Neuroendocrine Tumor AJCC v8


Pyogenic granuloma of skin and subcutaneous tissue


prostate-specific antigen N-glycosylated 78 (human)


interleukin-1 receptor antagonist protein isoform 1, signal peptide removed form (human)


interleukin-1 receptor antagonist protein isoform 1 (human)


metastatic malignant neoplasm in the eye


Stage II Appendix Neuroendocrine Tumor AJCC v7


Grade 5 Cerebrospinal Fluid Leakage, CTCAE


Advanced Vaginal Adenosquamous Carcinoma


Advanced Cervical Squamous Cell Carcinoma


Advanced Vaginal Squamous Cell Carcinoma


Advanced Renal Pelvis and Ureter Urothelial Carcinoma


Advanced Microsatellite Stable Ovarian Carcinoma


Advanced Microsatellite Stable Endometrial Carcinoma


Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified


Advanced Cervical Adenosquamous Carcinoma


hereditary continuous muscle fiber activity


basal ganglia calcification, idiopathic, 1


bromodomain-containing protein 4 isoform B (human)


bromodomain-containing protein 4 isoform C (human)


bromodomain-containing protein 4 isoform A (human)


Recurrent Grade II Lymphomatoid Granulomatosis


Recurrent Grade I Lymphomatoid Granulomatosis


Recurrent Childhood Lymphomatoid Granulomatosis


Extraocular Cutaneous Sebaceous Carcinoma


oxytocin-neurophysin 1 isoform 1 (human)


Grade 3 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


Grade 4 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


Grade 5 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


Grade 2 Cecum Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


chronic lymphoproliferative disorder of NK-cells


autosomal recessive early-onset Parkinson disease 23


autosomal recessive juvenile Parkinson disease 2


autosomal recessive early-onset Parkinson disease 7


Parkinson disease 22, autosomal dominant


autosomal recessive early-onset Parkinson disease 6


autosomal recessive Parkinson disease 14


Grade 3 Large Bowel Mucositis or Stomatitis by Clinical Examination Classification, CTCAE


receptor-type tyrosine-protein kinase FLT3 isoform h2 (human)


receptor-type tyrosine-protein kinase FLT3


receptor-type tyrosine-protein kinase FLT3, signal peptide removed form (human)


receptor-type tyrosine-protein kinase FLT3 isoform h1 (human)


Congenital insufficiency of pulmonary valve


Triple-Class Refractory Plasma Cell Myeloma


aspartate aminotransferase, mitochondrial, transit peptide removed pyridoxal phosphate lysine 1 (human)


Grade 4 Vein Infection Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE


hydroxycarboxylic acid receptor 2 isoform 1 (rat)


hydroxycarboxylic acid receptor 2 isoform 1 (mouse)


Blasts 9 Percent or Less of Peripheral Blood White Cells


TGF-beta receptor type-1, signal peptide removed ubiquitinated form (human)


Renal Tubular Acidosis Associated With Deafness


Refractory Chronic Myelomonocytic Leukemia


myasthenic syndrome, congenital, 1B, fast-channel


autosomal recessive congenital ichthyosis 3


autosomal recessive congenital ichthyosis 4B


presynaptic congenital myasthenic syndrome


congenital myasthenic syndrome with tubular aggregates


ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3


blepharophimosis-epicanthus inversus-ptosis due to copy number variations


ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome


camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye


blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome


myasthenic syndrome, congenital, 24, presynaptic


fibrosis of extraocular muscles, congenital, with synergistic divergence


metopic ridging-ptosis-facial dysmorphism syndrome


myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive


myasthenia, congenital, refractory to acetylcholinesterase inhibitors


keratosis follicularis spinulosa decalvans


congenital fibrosis of extraocular muscles type 1


blepharophimosis, ptosis, and epicanthus inversus syndrome


myasthenic syndrome, congenital, 25, presynaptic


fibrosis of extraocular muscles, congenital, 2


fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement


blepharophimosis-ptosis-epicanthus inversus syndrome type 2


congenital myasthenic syndromes with glycosylation defect


atrioventricular defect-blepharophimosis-radial and anal defect syndrome


ichthyosis, lamellar, autosomal dominant


fibrosis of extraocular muscles, congenital, 3c


autosomal recessive congenital ichthyosis 8


autosomal recessive congenital ichthyosis 6


blepharophimosis-ptosis-epicanthus inversus syndrome type 1


autosomal recessive congenital ichthyosis 5


postsynaptic congenital myasthenic syndrome


fibrosis of extraocular muscles, congenital, 5


keratosis follicularis spinulosa decalvans, autosomal dominant


blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome


autosomal recessive congenital ichthyosis 4A


keratosis follicularis spinulosa decalvans, X-linked


maternally-inherited progressive external ophthalmoplegia


ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1


mitogen-activated protein kinase 7 isoform h2 (human)


mitogen-activated protein kinase 7 isoform h3 (human)


mitogen-activated protein kinase 7, initiator methionine removed form (human)


mitogen-activated protein kinase 7, initiator methionine removed phosphorylated 2 (human)


mitogen-activated protein kinase 7 isoform 1 phosphorylated 1 (human)


mitogen-activated protein kinase 7 isoform h4 (human)


mitogen-activated protein kinase 7 isoform 1 (human)


combined immunodeficiency due to DOCK8 deficiency


heat shock protein HSP 90-alpha isoform 1 (human)


acrodysostosis 1 with or without hormone resistance


acrodysostosis 2 with or without hormone resistance


induced myeloid leukemia cell differentiation protein Mcl-1 isoform h1 (human)


Acute Megakaryoblastic Leukemia with NUP98-KDM5A


thymidine phosphorylase isoform h2 (human)


serine/threonine-protein kinase N3 phosphorylated 1 (human)


facioscapulohumeral muscular dystrophy 1


tissue-type plasminogen activator N-glycosylated 16 (human)


Stage I Rectal Neuroendocrine Tumor AJCC v8


acetylcholine receptor subunit delta isoform 1 (human)


acetylcholine receptor subunit delta, signal peptide removed form (human)


acetylcholine receptor subunit delta isoform h2 (human)


corrinoid adenosyltransferase MMAB, transit peptide removed form (human)


5-hydroxytryptamine receptor 2A isoform h2 (human)


chronic lymphocytic leukemia/small lymphocytic lymphoma


intrapelvic lymph node leukemic reticuloendotheliosis


pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma


chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation


transcriptional enhancer factor TEF-5, initiator methionine removed form (human)


Breast Classic Lobular Carcinoma In Situ Type B


Prognostic Stage IIIA Breast Cancer AJCC v8


Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma


Intraductal Micropapillary Breast Carcinoma


Solid papillary carcinoma in situ of breast


Invasive Breast Lobular Carcinoma, Solid Variant


Metastatic Triple-Negative Breast Carcinoma


Invasive Breast Lobular Carcinoma with Predominant In Situ Component


Invasive Breast Lobular Carcinoma, Alveolar Variant


High Grade Ductal Breast Carcinoma In Situ


Breast Carcinoma Metastatic in the Liver


Unresectable HER2-Negative Breast Carcinoma


Squamous Cell Carcinoma In Situ of the Nipple


Prognostic Stage 0 Breast Cancer AJCC v8


Refractory HER2-Positive Breast Carcinoma


Invasive Breast Solid Papillary Carcinoma


adenocarcinoma of breast with neuroendocrine differentiation


Metastatic Breast Inflammatory Carcinoma


Metastatic Breast Neuroendocrine Tumor G1


Breast Classic Lobular Carcinoma In Situ


Metastatic HER2-Negative Breast Carcinoma


Recurrent HER2-Positive Breast Carcinoma


Hormone Receptor-Positive Breast Carcinoma


Refractory Hormone Receptor-Positive Breast Carcinoma


Metastatic Breast Neuroendocrine Neoplasm


Inflammatory carcinoma of breast stage III


High Grade Breast Mucoepidermoid Carcinoma


Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma


Breast Cancer by AJCC v8 Prognostic Stage


Locally Advanced HER2-Negative Breast Carcinoma


Prognostic Stage IIB Breast Cancer AJCC v8


Low Grade Breast Adenosquamous Carcinoma


Refractory Triple-Negative Breast Carcinoma


Noninfiltrating intraductal papillary adenocarcinoma (morphologic abnormality)


Metastatic Breast Signet Ring Cell Carcinoma


Inflammatory carcinoma of breast recurrent


Breast Carcinoma with Choriocarcinomatous Features


Prognostic Stage II Breast Cancer AJCC v8


Anatomic Stage IIA Breast Cancer AJCC v8


Malignant neoplasm of nipple of female breast


Paget's disease and infiltrating duct carcinoma of breast


Invasive Breast Lobular Carcinoma, Tubulolobular Variant


Hormone Receptor-Negative Breast Carcinoma


Breast Carcinoma with Osseous Metaplasia


Unresectable Hormone Receptor-Positive Breast Carcinoma


Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component


Prognostic Stage IA Breast Cancer AJCC v8


Pleomorphic lobular carcinoma in situ of breast


Invasive micropapillary carcinoma of breast


Anatomic Stage IIIB Breast Cancer AJCC v8


Paget's disease and intraductal carcinoma of breast


Invasive Breast Carcinoma by Histologic Grade


Recurrent HER2-Negative Breast Carcinoma


Recurrent Invasive Breast Carcinoma of No Special Type


Breast Ductal Carcinoma In Situ, Comedo Type


Prognostic Stage III Breast Cancer AJCC v8


solid type ductal carcinoma in situ of breast


Prognostic Stage IV Breast Cancer AJCC v8


Anatomic Stage IIIC Breast Cancer AJCC v8


Prognostic Stage IIIC Breast Cancer AJCC v8


Metastatic Triple-Negative Breast Inflammatory Carcinoma


Breast Tall Cell Carcinoma with Reversed Polarity


Anatomic Stage IIB Breast Cancer AJCC v8


Unresectable HER2-Positive Breast Carcinoma


Breast Ductal Carcinoma In Situ and Lobular Carcinoma


Breast Ductal Carcinoma In Situ, Non-Comedo Type


Locally Advanced Triple-Negative Breast Carcinoma


Invasive Breast Lobular Carcinoma, Signet Ring Variant


Prognostic Stage I Breast Cancer AJCC v8


Anatomic Stage IIIA Breast Cancer AJCC v8


Metastatic Breast Squamous Cell Carcinoma


adenocarcinoma of breast with spindle cell metaplasia


Ductal Carcinoma In Situ with Microinvasion


Unresectable Breast Inflammatory Carcinoma


Refractory HER2-Negative Breast Carcinoma


Breast Carcinoma with Chondroid Metaplasia


Early Stage Triple-Negative Breast Carcinoma


Breast Ductal Carcinoma with Squamous Metaplasia


Metastatic Hormone Receptor-Positive Breast Carcinoma


Invasive Breast Lobular Carcinoma, Pleomorphic Variant


Breast Carcinoma with Melanotic Features


Breast Paget Disease without Invasive Carcinoma


Breast Classic Lobular Carcinoma In Situ Type A


Unresectable Triple-Negative Breast Carcinoma


Inflammatory carcinoma of breast stage IV


Metastatic HER2-Positive Breast Carcinoma


Prognostic Stage IIIB Breast Cancer AJCC v8


Breast Ductal Carcinoma In Situ, Low Grade


Prognostic Stage IB Breast Cancer AJCC v8


Metastatic Squamous Cell Carcinoma in the Breast


Prognostic Stage IIA Breast Cancer AJCC v8


Breast Carcinoma Metastatic in the Brain


Encapsulated Breast Papillary Carcinoma with Invasion


Breast Carcinoma with Osteoclast-Like Stromal Giant Cells


Anatomic Stage III Breast Cancer AJCC v8


Low Grade Breast Mucoepidermoid Carcinoma


Metastatic BRCA-Associated Breast Carcinoma


Invasive Breast Lobular Carcinoma with Extracellular Mucin


Breast Ductal Carcinoma In Situ, Intermediate Grade


Recurrent Hormone Receptor-Positive Breast Carcinoma


adenocarcinoma of breast with squamous metaplasia


Recurrent Triple-Negative Breast Carcinoma


Locally Advanced HER2-Positive Breast Carcinoma


Breast Carcinoma Metastatic in the Central Nervous System


Locally Advanced Hormone Receptor-Positive Breast Carcinoma


coagulation factor X N-glycosylated 2 (human)


interferon gamma isoform 1, signal peptide removed N-glycosylated 1 (human)


integrin beta-7 isoform 1, signal peptide removed form (human)


RAF proto-oncogene serine/threonine-protein kinase isoform 1 phosphorylated 3 (human)


RAF proto-oncogene serine/threonine-protein kinase isoform 1 (human)


RAF proto-oncogene serine/threonine-protein kinase isoform 1 phosphorylated 2 (human)


Grade 4 Oral Cavity Mucositis or Stomatitis by Clinical Examination Classification, CTCAE


progressive transformation of germinal centers


Low Phospho-AKT Immunohistochemical Expression


Intestinal Metaplasia of Columnar Epithelium


Neoplastic Cells with CD45 Dim-to-Negative Expression Present


Lymphoblasts with Surface Immunoglobulin Present


Loss or Reduction of Nuclear Histone H3 K28me3 Expression


Renal Dysplasia Due to Fetal Exposure to ACE Inhibitor or ARB


sinus histiocytosis with massive lymphadenopathy


Concentric Fibrosis of Intrahepatic Duct


Hurthle cell metaplasia of thyroid gland


Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B


Microcalcification Present in Neoplastic and Non-Neoplastic Tissue


Microcalcification Present in Neoplastic Tissue


Intestinal Metaplasia of Esophageal Mucosa


Microcalcification Present in Non-Neoplastic Tissue


Neoplastic Cells with CD38 Dim-to-Negative Expression Present


High Phospho-AKT Immunohistochemical Expression


Minimal Reticulin Fibrosis of the Bone Marrow


Refractory Malignant Gastrointestinal Stromal Tumor


Refractory Extraskeletal Myxoid Chondrosarcoma


Refractory Undifferentiated Pleomorphic Sarcoma


Refractory Childhood Soft Tissue Sarcoma


Refractory Desmoplastic Small Round Cell Tumor


Grade 1 Phrenic Nerve Dysfunction, CTCAE


Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7


Secondary Peripheral Atypical Cartilaginous Tumor


macular coloboma-cleft palate-hallux valgus syndrome


TGF-beta receptor type-2 sequence variant N435S (human)


sodium-dependent neutral amino acid transporter B(0)AT1 isoform 1 (human)


Secondary Peripheral Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Central Nervous System Mesenchymal Chondrosarcoma


Secondary Peripheral Chondrosarcoma, Grade 3


Unresectable Primary Central Chondrosarcoma


Locally Advanced Unresectable Primary Central Chondrosarcoma


Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Metastatic Primary Central Chondrosarcoma


Secondary Peripheral Chondrosarcoma, Grade 1


Secondary Peripheral Chondrosarcoma, Grade 2


Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Primary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


proto-oncogene tyrosine-protein kinase Src phosphorylated 1 (human)


protein-lysine 6-oxidase N-glycosylated 1 (human)


Grade 2 Pituitary Intra-Operative Injury, CTCAE


Grade 2 Lymphatic Infection with Unknown Absolute Neutrophil Count, CTCAE


alpha-2C adrenergic receptor isoform 1 (mouse)


Stage IIA Lung Small Cell Carcinoma AJCC v7


Unresectable Thymic Neuroendocrine Neoplasm


Thymic Carcinoma, Not Otherwise Specified


Stage IIA Lung Squamous Cell Carcinoma AJCC v7


Stage IA Lung Small Cell Carcinoma AJCC v7


Stage I Pleural Malignant Mesothelioma AJCC v8


Stage IIIA Lung Squamous Cell Carcinoma AJCC v7


Locally Advanced Lung Non-Small Cell Carcinoma


Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


Pleural Malignant Mesothelioma by AJCC v8 Stage


Mediastinal T Acute Lymphoblastic Leukemia


Metastatic Malignant Neoplasm in the Thoracic Cavity


Stage IIIB Pleural Malignant Mesothelioma AJCC v8


Mediastinal Germ Cell Tumor with Somatic-Type Malignancy


Invasive Lung Non-Mucinous Adenocarcinoma


Refractory Lung Non-Small Cell Squamous Carcinoma


Pleural mesothelioma malignant recurrent


Refractory Extensive Stage Lung Small Cell Carcinoma


Stage IIIB Thymic Epithelial Neoplasm AJCC v8


Cardiac Inflammatory Myofibroblastic Tumor


Stage III Pleural Malignant Mesothelioma AJCC v8


Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7


Unresectable Lung Non-Small Cell Squamous Carcinoma


Thymic carcinoma with adenoid cystic carcinoma-like features


Platinum-Resistant Lung Small Cell Carcinoma


Lung Squamous Cell Carcinoma, Small Cell Variant


Lung Non-Keratinizing Squamous Cell Carcinoma


Stage IA Lung Squamous Cell Carcinoma AJCC v7


Pleural Well Differentiated Papillary Mesothelial Tumor


Stage IA Pleural Malignant Mesothelioma AJCC v8


Locally Advanced Lung Large Cell Neuroendocrine Carcinoma


Pleural Proximal-Type Epithelioid Sarcoma


Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


Unresectable Lung Non-Small Cell Carcinoma


Resectable Lung Non-Small Cell Carcinoma


Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group


Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7


Epithelioid hemangioendothelioma of lung


Stage IB Pleural Malignant Mesothelioma AJCC v7


Metastatic Lung Large Cell Neuroendocrine Carcinoma


Lung Non-Small Cell Cancer by AJCC v7 Stage


Stage III Malignant Mediastinal Germ Cell Tumor


Stage IIIA Pleural Malignant Mesothelioma AJCC v8


Unresectable Malignant Thoracic Neoplasm


Mediastinal T Lymphoblastic Leukemia/Lymphoma


Metastatic Thymic Neuroendocrine Neoplasm


Advanced Lung Non-Small Cell Squamous Carcinoma


Stage IIIA Lung Small Cell Carcinoma AJCC v7


Mediastinal Mixed Nongerminomatous Germ Cell Tumor


Stage 0 Lung Adenocarcinoma AJCC v6 and v7


Locally Advanced Lung Adenosquamous Carcinoma


Stage IB Lung Squamous Cell Carcinoma AJCC v7


Stage I Malignant Mediastinal Germ Cell Tumor


Advanced Lung Large Cell Neuroendocrine Carcinoma


Metastatic Pleural Malignant Mesothelioma


Stage IB Pleural Malignant Mesothelioma AJCC v8


Stage II Lung Small Cell Carcinoma AJCC v7


Stage IB Non-Small Cell Lung Carcinoma AJCC v7


Stage IB Lung Small Cell Carcinoma AJCC v7


Congenital Peribronchial Myofibroblastic Tumor


Micronodular thymoma with lymphoid stroma


Stage IV Pleural Malignant Mesothelioma AJCC v7


Stage I Thymic Epithelial Neoplasm AJCC v8


Stage IA Lung Non-Small Cell Carcinoma AJCC v7


Thymic Epithelial Neoplasm by AJCC v8 Stage


Stage IV Malignant Mediastinal Germ Cell Tumor


Unresectable Pleural Malignant Mesothelioma


Stage IA Pleural Malignant Mesothelioma AJCC v7


malignant peripheral nerve sheath tumor (MPNST) of mediastinum


Lung Small Cell Carcinoma by AJCC v7 Stage


Stage II Pleural Malignant Mesothelioma AJCC v8


Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Stage IVA Thymic Epithelial Neoplasm AJCC v8


Stage IIIA Thymic Epithelial Neoplasm AJCC v8


Stage III Thymic Epithelial Neoplasm AJCC v8


Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Recurrent Combined Thymic Epithelial Neoplasm


Stage III Lung Small Cell Carcinoma AJCC v7


Minimally Invasive Mucinous Lung Adenocarcinoma


Stage I Pleural Malignant Mesothelioma AJCC v7


Unresectable Lung Non-Squamous Non-Small Cell Carcinoma


Unresectable Lung Large Cell Neuroendocrine Carcinoma


Locally Advanced Lung Neuroendocrine Neoplasm


keratinizing squamous cell carcinoma of lung


Stage II Pleural Malignant Mesothelioma AJCC v7


Stage IIIB Lung Small Cell Carcinoma AJCC v7


Bronchiolar adenoma/ciliated muconodular papillary tumor


childhood mediastinal neurogenic neoplasm


Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


Stage IV Lung Squamous Cell Carcinoma AJCC v7


Resectable Pleural Malignant Mesothelioma


Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


malignant cardiac peripheral nerve sheath neoplasm


Lung Squamous Cell Carcinoma, Papillary Variant


Extramedullary Disease in Plasma Cell Myeloma Involving the Lung


Chest Wall Plexiform Fibrohistiocytic Tumor


Stage IIB Lung Small Cell Carcinoma AJCC v7


Stage II Thymic Epithelial Neoplasm AJCC v8


Platinum-Sensitive Lung Small Cell Carcinoma


Lung Squamous Cell Carcinoma by AJCC v7 Stage


Locally Advanced Pleural Malignant Mesothelioma


malignant melanocytic peripheral nerve sheath tumor of mediastinum


Basaloid squamous cell carcinoma of lung


Stage IV Thymic Epithelial Neoplasm AJCC v8


Stage II Malignant Mediastinal Germ Cell Tumor


Colorectal Carcinoma Metastatic in the Lung


Stage IIIB Lung Squamous Cell Carcinoma AJCC v7


Refractory Pleural Malignant Mesothelioma


Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy


Refractory Lung Non-Small Cell Carcinoma


Unresectable Lung Neuroendocrine Neoplasm


Stage IIB Lung Squamous Cell Carcinoma AJCC v7


Prostate Carcinoma Metastatic in the Lung


Thymic Adenocarcinoma, Not Otherwise Specified


Pleural Malignant Mesothelioma by AJCC v7 Stage


Stage IV Pleural Malignant Mesothelioma AJCC v8


Stage I Lung Small Cell Carcinoma AJCC v7


Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7


Malignant Mediastinal Nongerminomatous Germ Cell Tumor


Pleural mesothelioma malignant localised


Malignant Intrathoracic Paravertebral Paraganglioma


Non-mucinous adenocarcinoma in situ of lung


Stage III Pleural Malignant Mesothelioma AJCC v7


Metastatic Lung Non-Small Cell Carcinoma


Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma


Metastatic Lung Non-Small Cell Squamous Carcinoma


Locally Advanced Lung Non-Small Cell Squamous Carcinoma


Lung Carcinoma Metastatic in the Central Nervous System


Stage IV Lung Small Cell Carcinoma AJCC v7


Refractory Lung Non-Squamous Non-Small Cell Carcinoma


Lung Mixed Squamous Cell and Glandular Papilloma


Lung Squamous Cell Carcinoma, Clear Cell Variant


autosomal recessive severe congenital neutropenia due to JAGN1 deficiency


primary immunodeficiency syndrome due to p14 deficiency


autosomal recessive severe congenital neutropenia due to CXCR2 deficiency


autosomal recessive severe congenital neutropenia


neutropenia, severe congenital, 8, autosomal dominant


neutropenia, severe congenital, 2, autosomal dominant


autosomal recessive severe congenital neutropenia due to CSF3R deficiency


neutropenia, lethal congenital, with eosinophilia


neutropenia, severe congenital, 1, autosomal dominant


autosomal recessive severe congenital neutropenia due to G6PC3 deficiency


autosomal dominant severe congenital neutropenia


neutropenia, severe congenital, 9, autosomal dominant


ribonucleoside-diphosphate reductase large subunit isoform 1 (human)


porokeratosis 8, disseminated superficial actinic type


porokeratosis 6, disseminated superficial actinic type


disseminated superficial actinic porokeratosis


porokeratosis 5, disseminated superficial actinic type


porokeratosis 4, disseminated superficial actinic type


porokeratosis 3, disseminated superficial actinic type


porokeratosis plantaris palmaris et disseminata


infiltrating nipple syringomatous adenoma


breasts and/or nipples, aplasia or hypoplasia of, 2


isolated congenital breast hypoplasia/aplasia


breast fibrocystic change, proliferative type


linear and whorled nevoid hypermelanosis


salivary gland type cancer of the breast


familial juvenile hypertrophy of the breast


craniofrontonasal dysplasia-Poland anomaly syndrome


breasts and/or nipples, aplasia or hypoplasia of, 1


non-proliferative fibrocystic change of the breast


U5 small nuclear ribonucleoprotein 200 kDa helicase isoform 1 (human)


Recurrent Cutaneous Melanoma of the Extremity


mitogen-activated protein kinase 9 isoform hAlpha-2 (human)


mitogen-activated protein kinase 9 phosphorylated 1 (human)


mitogen-activated protein kinase 9 isoform hBeta-1 (human)


mitogen-activated protein kinase 9 isoform Alpha-1 (human)


mitogen-activated protein kinase 9 isoform h5 (human)


mitogen-activated protein kinase 9 isoform hBeta-2 (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant R190Q (human)


Trichomonas vaginitis urogenital infection


Grade 3 Pulmonary Artery Intra-Operative Injury, CTCAE


voltage-dependent L-type calcium channel subunit alpha-1S isoform r1 (rat)


Advanced Head and Neck Squamous Cell Carcinoma


Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


Advanced Oral Cavity Squamous Cell Carcinoma


Locally Advanced Nasal Cavity Squamous Cell Carcinoma


Metastatic Nasal Cavity Squamous Cell Carcinoma


Unresectable Nasal Cavity Squamous Cell Carcinoma


keratinizing squamous cell carcinoma of nasal cavity


serine/threonine-protein kinase 25 isoform h2 (human)


serine/threonine-protein kinase 25 isoform 1 (human)


serine/threonine-protein kinase 25 isoform h3 (human)


Palmoplantar keratoderma with leukoplakia


ephrin type-B receptor 1, signal peptide removed form (human)


ephrin type-B receptor 1, signal peptide removed phosphorylated 1 (human)


maltase-glucoamylase O-glycosylated 1 (human)


amyloid-beta precursor protein sequence variant A692G (human)


glutamate dehydrogenase 2, mitochondrial, transit peptide removed form (human)


transcription factor p65 isoform 1 acetylated 1 (human)


Maternally Derived Graft Versus Host Disease


potassium voltage-gated channel subfamily C member 2 isoform KSHIIIA.1 (rat)


potassium voltage-gated channel subfamily C member 2 isoform 3 (human)


Grade 2 Rectum Mucositis or Stomatitis by Clinical Examination Classification, CTCAE


Peritoneum injury with open wound into cavity


neurotensin receptor type 2 isoform 1 (mouse)


acute monoblastic/monocytic leukemia in relapse


Refractory Acute Monoblastic and Monocytic Leukemia


Adult Acute Monoblastic and Monocytic Leukemia


Childhood Acute Monoblastic and Monocytic Leukemia


X-linked acrogigantism due to a point mutation


Periventricular Hemorrhage of the Newborn


Transient Leukemoid Reaction of the Newborn


Intraventricular (nontraumatic) hemorrhage, grade 1, of fetus and newborn


Intraparenchymal Hemorrhage of the Newborn


mitochondrial complex 1 deficiency, nuclear type 14


coagulation factor VII N-glycosylated 10 (human)


Resectable Adenocarcinoma of Unknown Primary


macrophage migration inhibitory factor isoform 1 (human)


macrophage migration inhibitory factor, initiator methionine removed form (human)


anemia due to erythrocyte enzyme disorder


glycogen storage disease due to phosphoglycerate mutase deficiency


hemolytic anemia due to diphosphoglycerate mutase deficiency


Uridine monophosphate hydrolase deficiency


Intermediate (Locally Aggressive) Blood Vessel Neoplasm


Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma


Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm


B-lymphocyte antigen CD19, signal peptide removed form (human)


B-lymphocyte antigen CD19, signal peptide removed phosphorylated 1 (human)


Transforming Growth Factor-Beta Overexpression


Fibroblast Growth Factor 1 Overexpression


Presence of ERBB2 Overexpressing Disseminated Tumor Cells


Fibroblast Growth Factor 2 Overexpression


Grade 1 Lymphocyte Count Decreased, CTCAE


Grade 3 Fallopian Tube Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


hypertrophic or verrucous lupus erythematosus


Pancreatic Macrocystic Serous Cystadenoma


Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma


Locally Advanced Gastrointestinal Stromal Tumor


Metastatic Gastrointestinal Stromal Tumor


cyclin-dependent kinase 16 isoform 1 (human)


cyclin-dependent kinase 16 isoform h2 (human)


cyclin-dependent kinase 16 isoform h3 (human)


mitochondrial complex 1 deficiency, nuclear type 16


type I iodothyronine deiodinase isoform h5 (human)


type I iodothyronine deiodinase isoform h3 (human)


type I iodothyronine deiodinase isoform h9 (human)


type I iodothyronine deiodinase isoform h4 (human)


type I iodothyronine deiodinase isoform h8 (human)


type I iodothyronine deiodinase isoform h2 (human)


type I iodothyronine deiodinase isoform h6 (human)


type I iodothyronine deiodinase isoform h1 (human)


type I iodothyronine deiodinase isoform h7 (human)


NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial, transit peptide removed form (human)


nystagmus 3, congenital, autosomal dominant


Chest Pain Along Right Upper Sternal Border


fructose-1,6-bisphosphatase 1, initiator methionine removed form (human)


fructose-1,6-bisphosphatase 1 isoform 1 (human)


coagulation factor XII O-glycosylated 4 (human)


coagulation factor XII O-glycosylated 11 (human)


coagulation factor XII O-glycosylated 2 (human)


coagulation factor XII O-glycosylated 10 (human)


coagulation factor XII O-glycosylated 1 (human)


coagulation factor XII O-glycosylated 9 (human)


coagulation factor XII O-glycosylated 7 (human)


coagulation factor XII O-glycosylated 8 (human)


coagulation factor XII O-glycosylated 5 (human)


coagulation factor XII O-glycosylated 3 (human)


coagulation factor XII O-glycosylated 6 (human)


coagulation factor XII, signal peptide removed form (human)


phosphorylase b kinase gamma catalytic chain, liver/testis isoform isoform h2 (human)


phosphorylase b kinase gamma catalytic chain, liver/testis isoform isoform 1 (human)


persistent polyclonal B-cell lymphocytosis


peroxisomal acyl-coenzyme A oxidase 3 isoform h2 (human)


Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma


voltage-dependent L-type calcium channel subunit alpha-1D isoform Neuronal-type (human)


Advanced Pancreatic Neuroendocrine Tumor


Pancreatic neuroendocrine tumor metastatic


Locally Advanced Pancreatic Neuroendocrine Tumor


short transient receptor potential channel 4 isoform beta (human)


short transient receptor potential channel 4 isoform beta (mouse)


spastic paraplegia, intellectual disability, nystagmus, and obesity;


cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform PDE4B1 (human)


gamma-aminobutyric acid receptor subunit gamma-3 isoform 1 (mouse)


gamma-aminobutyric acid receptor subunit gamma-3


gamma-aminobutyric acid receptor subunit gamma-3 isoform h2 (human)


gamma-aminobutyric acid receptor subunit gamma-3 isoform 1 (rat)


gamma-aminobutyric acid receptor subunit gamma-3, signal peptide removed form (human)


gamma-aminobutyric acid receptor subunit gamma-3 isoform 1 (human)


paraparetic variant of Guillain-Barre syndrome


Recurrent Prostate Acinar Adenocarcinoma


Adenocarcinoma of the prostate recurrent


Biochemically Recurrent Prostate Carcinoma


Grade 3 Phantom Pain Associated with Missing Limb, CTCAE


developmental and epileptic encephalopathy, 77


multiple congenital anomalies-hypotonia-seizures syndrome 3


multiple congenital anomalies-hypotonia-seizures syndrome 2


cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform hN3 (human)


Grade 1 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Generalized or Specific Area Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Lower Extremity Muscle Weakness, CTCAE Not Due to Neuropathy


Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Upper Extremity Muscle Weakness, CTCAE Not Due to Neuropathy


Grade 1 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Trunk Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Extraocular Muscle Weakness Not Due to Neuropathy, CTCAE


Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Upper Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Whole Body and Generalized Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Facial Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 1 Left-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 4 Lower Extremity Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Pelvic Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 2 Ocular Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 5 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


Grade 3 Right-Sided Muscle Weakness Not Due to Neuropathy, CTCAE


protein-tyrosine kinase 6 isoform h2 (human)


Phyllodes Tumor of Anogenital Mammary-Type Glands


paternal uniparental disomy of chromosome 7


Injury to stomach with open wound into cavity


Complex Endometrial Hyperplasia with Atypia


Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor


angiotensin-converting enzyme 2 isoform 1 (rat)


polydactyly of an index finger, unilateral


polydactyly of an index finger, bilateral


polydactyly of a biphalangeal thumb, unilateral


mesoaxial synostotic syndactyly with phalangeal reduction


polydactyly of a biphalangeal thumb, bilateral


familial avascular necrosis of femoral head


protein-L-isoaspartate(D-aspartate) O-methyltransferase, initiator methionine removed form (human)


Advanced Malignant Small Intestinal Neoplasm


Malignant neoplasm of small intestine, incl duodenum metastatic


Locally Advanced Small Intestinal Carcinoma


Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma


Small intestine adenocarcinoma metastatic


Advanced Small Intestinal Neuroendocrine Carcinoma


Locally Advanced Small Intestinal Adenocarcinoma


Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma


Metastatic Small Intestinal Neuroendocrine Carcinoma


muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14


muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14


autosomal recessive limb-girdle muscular dystrophy type 2T


ENSAT Stage III Adrenal Cortex Carcinoma


serine/threonine-protein kinase Chk1 isoform 1 (human)


glycine receptor subunit beta isoform h1 (human)


glycine receptor subunit beta isoform h2 (human)


glycine receptor subunit beta, signal peptide removed form (human)


Grade 1 Atrial Tachycardia or Paroxysmal Atrial Tachycardia, CTCAE


Open fracture of carpal bone, unspecified


trichorhinophalangeal syndrome, type III


trichorhinophalangeal syndrome type I or III


autosomal dominant nonsyndromic hearing loss 65


Asymptomatic COVID-19 Infection Laboratory-Confirmed


Symptomatic COVID-19 Infection Laboratory-Confirmed


calcium/calmodulin-dependent protein kinase type IV phosphorylated 2 (human)


Pancreatic Well Differentiated Ductal Adenocarcinoma


steroid hormone receptor ERR1 isoform 1 (mouse)


steroid hormone receptor ERR1 isoform 2 (human)


serine/threonine-protein kinase STK11 isoform 1 (human)


Grade 1 Pharynx Mucositis or Stomatitis by Functional or Symptomatic Classification, CTCAE


B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


Grade 4 Trachea Obstruction and Stenosis, CTCAE


Grade 3 Supraventricular Extrasystoles, CTCAE


Grade 4 Supraventricular Extrasystoles, CTCAE


Grade 2 Supraventricular Extrasystoles, CTCAE


Grade 5 Supraventricular Extrasystoles, CTCAE


Grade 1 Supraventricular Extrasystoles, CTCAE


Grade 4 Other Musculoskeletal and Soft Tissue, CTCAE


Hermansky-Pudlak syndrome without pulmonary fibrosis


minimal pigment oculocutaneous albinism type 1


severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome


deaf blind hypopigmentation syndrome, Yemenite type


hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome


terminal osseous dysplasia-pigmentary defects syndrome


nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome


dyschromatosis universalis hereditaria 1


linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies


osteopathia striata-pigmentary dermopathy-white forelock syndrome


autosomal dominant oculocutaneous albinism


piebald trait-neurologic defects syndrome


temperature-sensitive oculocutaneous albinism type 1


oculocerebral hypopigmentation syndrome, Cross type


pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome


deafness, congenital, with total albinism


dyschromatosis universalis hereditaria 2


hyperpigmentation with or without hypopigmentation, familial progressive


leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome


dyschromatosis universalis hereditaria 3


familial progressive hyper- and hypopigmentation


microcephaly 9, primary, autosomal recessive


phosphatidylinositol 4-phosphate 5-kinase type-1 alpha isoform h4 (human)


NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial isoform 1 (human)


Neoplastic Plasma Cells 30 Percent or More of Bone Marrow Nucleated Cells


Blasts Under 20,000 in Peripheral Blood White Cells


Blasts Under 25 Percent of Bone Marrow Nucleated Cells


Myeloblasts 1 Percent or Less of Peripheral Blood White Cells


Blasts 20-30 Percent of Bone Marrow Nucleated Cells


Blasts Expressing T-Lymphoid and Myeloid Markers Present


Blasts 30 Percent or More of Bone Marrow Nucleated Cells


Lymphoblasts More Than 50 Percent of Bone Marrow Nucleated Cells


Bone Marrow Dysplasia Present in Less than 10 Percent of Myeloid Cells


Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells


Blasts More than 10 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 20 Percent or More of Peripheral Blood White Cells


Myeloblasts 5 Percent or More of Peripheral Blood White Cells


Blasts 6-24 Percent of Bone Marrow Nucleated Cells


Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells


Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells


Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells


Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells


Blasts 20 Percent or More of Bone Marrow Nucleated Cells


Blasts 5-9 Percent of Bone Marrow Nucleated Cells


Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines


Blasts Expressing CD56 and Immature T-Cell Markers Present


Blasts More than 60 Percent of Bone Marrow Nucleated Cells


Absolute Neutrophil Count Greater than or Equal to 500/mm3


Eosinophilia Greater than 1500 cells per Microliter


Blasts 20 Percent or Less of Bone Marrow Nucleated Cells


Lymphoblasts 1 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 10-20 Percent of Bone Marrow Nucleated Cells


Blasts Under 30 Percent of Bone Marrow Nucleated Cells


Neoplastic Promonocytes in Bone Marrow Markedly Increased


Blasts Under 15 Percent of Peripheral Blood White Cells


Immature Granulocytes in Peripheral Blood Under 10 Percent


Myeloblasts Under 20 Percent of Peripheral Blood White Cells


Blasts More than 15 Percent of Bone Marrow Nucleated Cells


Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level


Fetal Circulation with Increased Nucleated Erythrocytes


Blasts 1 Percent or More of Peripheral Blood White Cells


Blasts 5 Percent or More of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present


Ring Sideroblasts Under 15 Percent of Erythroid Precursors


Blasts 10-19 Percent of Peripheral Blood White Cells


Immature Myeloid Cells Increased in Bone Marrow


Neoplastic Plasma Cells More than 50 Percent of Bone Marrow Nucleated Cells


Myeloblasts Under 1 Percent of Peripheral Blood White Cells


Neoplastic Plasma Cells More than 20 Percent of Bone Marrow Nucleated Cells


Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells


Blasts Less than 0.01 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 5 Percent or Less of Bone Marrow Nucleated Cells


Myeloblasts Under 10 Percent of Peripheral Blood White Cells


Blasts More than 10000 of Peripheral Blood White Cells


T-Cells Absent, T-Cell Receptor Signaling Defective and Natural Killer Cells and B-Cells Normal


Neoplastic Plasma Cells Under 5 Percent of Bone Marrow Nucleated Cells


Blasts 10-19 Percent of Bone Marrow Nucleated Cells


Blasts 5 Percent or More of Peripheral Blood White Cells


Blasts 50 Percent or More of Bone Marrow Nucleated Cells


Blasts 9 Percent or Less of Bone Marrow Nucleated Cells


Dual Population of Bone Marrow Blasts Present


Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells


Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 0.01 Percent or More of Bone Marrow Nucleated Cells


Blasts Greater than or Equal to 5000 per mL


Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells


Blasts More Than 5 Percent of Peripheral Blood White Cells


Monoblasts 20 Percent or More of Bone Marrow Nucleated Cells


Blasts 30 Percent or Less of Peripheral Blood White Cells


Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells


Blasts Under 20 Percent of Bone Marrow Nucleated Cells


Blasts 10 Percent or Less of Bone Marrow Nucleated Cells


Myeloblasts Under 2 Percent of Peripheral Blood White Cells


Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines


Blasts Under 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 5 Percent of Peripheral Blood White Cells


T-Cells and Natural Killer Cells Absent B-Cells Normal


Immature Granulocytes in Peripheral Blood Increased


Blasts 6-25 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or Less of Bone Marrow Nucleated Cells


Blasts 5-20 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells


Atypical Lymphocytes Present in Peripheral Blood


Blasts 0 Percent of Peripheral Blood White Cells


Hypereosinophilia of Undetermined Significance


Blasts 5-30 Percent of Bone Marrow Nucleated Cells


gp100:154-162-Reactive Peripheral Blood Lymphocytes Present


Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells


Blasts 5-25 Percent of Bone Marrow Nucleated Cells


Blasts 2-4 Percent of Peripheral Blood White Cells


Blasts 1 Percent of Peripheral Blood White Cells


Lymphoblasts 5-25 Percent of Bone Marrow Nucleated Cells


Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells


Myeloblasts More than 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 30 Percent of Peripheral Blood White Cells


Mast Cells 10 Percent or More of Peripheral Blood White Cells


Neoplastic Plasma Cells Present in Bone Marrow


Neoplastic Plasma Cells 20 Percent or Less of Bone Marrow Nucleated Cells


Blasts 21-30 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells


Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells


CD5-Positive Blast Cells Greater than 50 Percent


Blasts More than 25 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 5 Percent or More of Peripheral Blood White Cells


Blasts 20,000 or Less of Peripheral Blood White Cells


Blasts More than 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 10 Percent of Bone Marrow Nucleated Cells


Blasts Less Than 50 Percent of Bone Marrow Nucleated Cells


Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood


Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells


Myeloblasts Under 5 Percent of Peripheral Blood White Cells


T-Cells and B-Cells Absent and Natural Killer Cells Normal


Blasts 15 Percent or Less of Bone Marrow Nucleated Cells


Lymphoblasts Less than 5 Percent of Bone Marrow Nucleated Cells


Blasts 2 Percent or More of Peripheral Blood White Cells


Blasts 6 Percent or More of Bone Marrow Nucleated Cells


Blasts Under 15 Percent of Bone Marrow Nucleated Cells


Blasts 50 Percent or Less of Bone Marrow Nucleated Cells


T-Cells, B-Cells and Natural Killer Cells Absent


Blasts 20 Percent or Less of Peripheral Blood White Cells


Neoplastic Plasma Cells 10-60 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells Under 5 Percent of Peripheral Blood White Cells


Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells


Blasts 5 Percent or Less of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells Between 20 and 50 Percent of Bone Marrow Nucleated Cells


Atypical Lymphocytes Present in Bone Marrow


Neoplastic Plasma Cells Under 50 Percent of Bone Marrow Nucleated Cells


Blasts 25 Percent or Less of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 60 Percent or More of Bone Marrow Nucleated Cells


Blasts More than 20 Percent of Bone Marrow Nucleated Cells


Blasts 60 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 10-59 Percent of Bone Marrow Nucleated Cells


Neoplastic Promyelocytes in Bone Marrow Markedly Increased


Myeloblasts 1 Percent of Peripheral Blood White Cells


Hemoglobinuria due to hemolysis from external causes


Neoplastic Plasma Cells Under 20 Percent of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present


Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid and Myeloid Markers Present


Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells


Blasts 25 Percent or More of Bone Marrow Nucleated Cells


Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells


Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells


Blasts 5-19 Percent of Bone Marrow Nucleated Cells


Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells


Homozygous Hemoglobin C or E, Non-Disease


T-Cells Absent and Normal Natural Killer Cells and B-Cells


Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells


Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells


Ring Sideroblasts 15 Percent or More of Erythroid Precursors


Blasts 30,000 or Less of Peripheral Blood White Cells


Myeloblasts 5 Percent or Less of Bone Marrow Nucleated Cells


Blasts 11-20 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 30 Percent or Less of Bone Marrow Nucleated Cells


Lymphoma Cells More than 25 Percent of Bone Marrow Nucleated Cells


Blasts Under 20 Percent of Peripheral Blood White Cells


Bone Marrow Blasts Percentage Decreased by 5 to 25 Percent


Blasts 5 Percent or Less of Peripheral Blood White Cells


Blasts 30 Percent or Less of Bone Marrow Nucleated Cells


BCR-JAK2 Fusion in Hematologic Malignancies


Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells


Blasts 5-19 Percent of Peripheral Blood White Cells


Blasts 5-10 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or More of Peripheral Blood White Cells


Blasts 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 2 Percent or More of Bone Marrow Nucleated Cells


Blasts 1 Percent or More of Bone Marrow Nucleated Cells


Blasts Increased by Greater than or Equal to 50 Percent


Blasts Under 10 Percent of Peripheral Blood White Cells


Neoplastic Plasma Cells More than 5 Percent of Peripheral Blood White Cells


Blasts 6-19 Percent of Bone Marrow Nucleated Cells


fatty acyl-CoA reductase 1 dysregulation


monoclonal mast cell activation syndrome


Mixed phenotype acute leukemia T/myeloid


voltage-dependent L-type calcium channel subunit alpha-1D isoform r7 (rat)


Prostate Acinar Adenocarcinoma, Atrophic Variant


maltase-glucoamylase O-glycosylated 6 (human)


maltase-glucoamylase O-glycosylated 7 (human)


maltase-glucoamylase O-glycosylated 3 (human)


maltase-glucoamylase O-glycosylated 4 (human)


maltase-glucoamylase O-glycosylated 5 (human)


maltase-glucoamylase O-glycosylated 2 (human)


NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial isoform h3 (human)


serine/threonine-protein kinase SIK3 isoform h2 (human)


serine/threonine-protein kinase SIK3 isoform h1 (human)


serine/threonine-protein kinase SIK3 isoform h3 (human)


serine/threonine-protein kinase SIK3 isoform h4 (human)


potassium voltage-gated channel subfamily C member 2 isoform h5 (human)


multiple epiphyseal dysplasia, with severe proximal femoral dysplasia


focal adhesion kinase 1, initiator methionine removed phosphorylated 3 (human)


non-severe combined immunodeficiency due to polymerase delta deficiency


congenital corneal opacities, cornea guttata, and corectopia


active cochleovestibular Meniere disease


X-linked mixed hearing loss with perilymphatic gusher


voltage-dependent L-type calcium channel subunit alpha-1C isoform h31 (human)


hyperuricemic nephropathy, familial juvenile type 4


polyunsaturated fatty acid lipoxygenase ALOX15B isoform B (human)


polyunsaturated fatty acid lipoxygenase ALOX15B


polyunsaturated fatty acid lipoxygenase ALOX15B isoform D (human)


polyunsaturated fatty acid lipoxygenase ALOX15B isoform C (human)


polyunsaturated fatty acid lipoxygenase ALOX15B isoform A (human)


potassium voltage-gated channel subfamily H member 4 isoform 1 (human)


HLA class I histocompatibility antigen, A-1 alpha chain (human)


lipoprotein lipase, signal peptide removed form (human)


microtubule-associated protein tau isoform Tau-A (human)


immunoglobulin heavy constant gamma 4 N-glycosylated 5 (human)


signal transducer and activator of transcription 3 isoform 1 acetylated 1 (human)


gamma-aminobutyric acid receptor subunit alpha-6, signal peptide removed form (human)


histamine H3 receptor isoform h7 (human)


tyrosine-protein kinase Mer N-glycosylated 1 (human)


peroxisome proliferator-activated receptor delta isoform h3 (human)


acid-sensing ion channel 1 isoform r2 (rat)


T-cell surface glycoprotein CD3 delta chain isoform h1 (human)


serine/threonine-protein kinase B-raf isoform m1 phosphorylated 1 (mouse)


antithrombin-III N-glycosylated 3 (human)


fibroblast growth factor receptor 1 N-glycosylated 2 (human)


phosphatidylinositol 5-phosphate 4-kinase type-2 alpha isoform h1 (human)


BMP receptor type-2 sequence variant R491W (human)


HLA class I histocompatibility antigen, A-74 alpha chain (human)


M-phase inducer phosphatase 3 phosphorylated 2 (human)


voltage-dependent L-type calcium channel subunit alpha-1C isoform h34 (human)


NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial, transit peptide removed form (human)


[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, transit peptide removed form (human)


fibroblast growth factor receptor 4 O-glycosylated 1 (human)


thromboxane-A synthase isoform h3 (human)


4-aminobutyrate aminotransferase, mitochondrial isoform 1 (mouse)


calcium/calmodulin-dependent protein kinase type II subunit alpha


thromboxane-A synthase isoform h4 (human)


eyes absent homolog 2 phosphorylated form (human)


gamma-aminobutyric acid receptor subunit alpha-3 N-glycosylated 5 (rat)


fibroblast growth factor receptor 2 isoform h9 (human)


amiloride-sensitive sodium channel subunit beta isoform h2 (human)


NPC1-like intracellular cholesterol transporter 1


potassium voltage-gated channel subfamily H member 5 isoform 2 (human)


microtubule-associated protein tau sequence variant P332S (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform h9 (human)


electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial isoform h1 (human)


serine/threonine-protein kinase MARK2 isoform h11 (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform h10 (human)


aspartyl/asparaginyl beta-hydroxylase isoform h4 (human)


alpha-1A adrenergic receptor isoform h2 (human)


TRAF2 and NCK-interacting protein kinase isoform h8 (human)


solute carrier family 22 member 6 isoform h2 (human)


beta-hexosaminidase subunit beta N-glycosylated 10 (human)


5'-AMP-activated protein kinase catalytic subunit alpha-1


AP-2 complex subunit sigma isoform 1 (rat)


mu-type opioid receptor isoform h6 (human)


lysosomal alpha-glucosidase N-glycosylated 2 (human)


voltage-dependent calcium channel subunit alpha-2/delta-2, signal peptide removed form (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform hPDE4C6 (human)


serine/threonine-protein kinase Sgk3 isoform h2 (human)


sphingosine-1-phosphate lyase 1 pyridoxal phosphate lysine 1 (human)


vascular endothelial growth factor receptor 1 isoform h7 (human)


amyloid-beta precursor protein isoform APP714 (human)


glycogen synthase kinase-3 alpha phosphorylated 1 (human)


transferrin receptor protein 1 N-glycosylated 9 (human)


microtubule-associated protein tau sequence variant S352L (human)


major prion protein N-glycosylated 32 (mouse)


mu-type opioid receptor isoform h17 (human)


high affinity immunoglobulin gamma Fc receptor I, signal peptide removed form (human)


maternal embryonic leucine zipper kinase isoform h5 (human)


all-trans-retinol dehydrogenase [NAD(+)] ADH4 isoform h1 (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4B phosphorylated 1 (human)


thyrotropin-releasing hormone receptor type 1


interferon-induced, double-stranded RNA-activated protein kinase isoform h2 (human)


placenta growth factor, signal peptide removed form (human)


metabotropic glutamate receptor 1 isoform r1C (rat)


G2/mitotic-specific cyclin-B3 isoform h2 (human)


short transient receptor potential channel 4 isoform gamma (human)


immunoglobulin heavy constant epsilon N-glycosylated 28 (human)


potassium channel subfamily T member 1 isoform h2 (human)


sodium/myo-inositol cotransporter 2 O-glycosylated 1 (human)


vasopressin V2 receptor isoform h2 (human)


HLA class I histocompatibility antigen, A alpha chain isoform h2 (human)


RAF proto-oncogene serine/threonine-protein kinase phosphorylated 6 (human)


major prion protein N-glycosylated 4 (mouse)


sterol 26-hydroxylase, mitochondrial, transit peptide removed form (human)


UDP-glucuronosyltransferase 1-6, signal peptide removed form (human)


STE20-like serine/threonine-protein kinase isoform h2 (human)


dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform h4 (human)


high affinity nerve growth factor receptor isoform TrkA-I mature form unphosphorylated and N-glycosylated 1 (human)


steroid 21-hydroxylase isoform h2 (human)


amyloid-beta precursor protein sequence variant I716F (human)


acyl-CoA dehydrogenase family member 10 isoform h4 (human)


serine/threonine-protein kinase MRCK alpha isoform h2 (human)


neuronal acetylcholine receptor subunit alpha-4 sequence variant T529A (mouse)


tyrosine-protein kinase HCK, initiator methionine removed form (human)


microtubule-associated protein tau sequence variant L315R (human)


apoptosis regulator Bcl-2 isoform 1 phosphorylated 3 (human)


microtubule-associated protein tau sequence variant A239T (human)


interleukin-5 receptor subunit alpha, signal peptide removed form (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant G179S (human)


potassium voltage-gated channel subfamily KQT member 2 isoform 10 (mouse)


metabotropic glutamate receptor 8 isoform 1 (mouse)


exopolyphosphatase PRUNE1 isoform h2 (human)


fibroblast growth factor receptor 1 isoform AlphaA3 (human)


gamma-aminobutyric acid receptor subunit rho-1, signal peptide removed form (human)


alpha-1-acid glycoprotein 1 N-glycosylated 13 (human)


SYK/ZAP-70 family tyrosine-protein kinase


myosin light chain kinase, smooth muscle isoform h8 (human)


angiotensin-converting enzyme N-glycosylated 1 (rat)


transient receptor potential cation channel subfamily V member 4 phosphorylated 1 (mouse)


serine hydroxymethyltransferase, cytosolic isoform h4 (human)


major prion protein N-glycosylated 18 (mouse)


5'-AMP-activated protein kinase subunit beta-1


vascular endothelial growth factor receptor 2 N-glycosylated 32 (mouse)


coagulation factor X N-glycosylated 15 (human)


serine/threonine-protein kinase receptor R3 sequence variant A482V (human)


protein phosphatase 3 catalytic subunit alpha


major prion protein N-glycosylated 8 (mouse)


epidermal growth factor receptor N-glycosylated 7 (human)


serine/threonine-protein kinase MRCK alpha isoform h6 (human)


NT-3 growth factor receptor isoform 2 (human)


sodium channel subunit beta-4 isoform h3 (human)


coagulation factor VII N-glycosylated 2 (human)


non-receptor tyrosine-protein kinase TNK1


gamma-aminobutyric acid receptor subunit rho-1 isoform h1 (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant S373P (human)


ribosomal protein S6 kinase alpha-1 phosphorylated 1 (human)


equilibrative nucleoside transporter 1 O-glycosylated 1 (human)


platelet-derived growth factor receptor beta isoform h2 (human)


protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha, initiator methionine removed form (human)


ATP-binding cassette sub-family C member 4 isoform h2 (human)


serine/threonine-protein kinase tousled-like 1 isoform h5 (human)


adenylate cyclase type 8 isoform r2 (rat)


B-cell receptor CD22, signal peptide removed form (human)


gamma-aminobutyric acid receptor subunit alpha-2 isoform 1 (mouse)


vascular endothelial growth factor A isoform hL-VEGF189 (human)


membrane-associated progesterone receptor component 1 isoform 1 (human)


dehydrogenase/reductase SDR family member 9


farnesyl pyrophosphate synthase isoform 1 (mouse)


ephrin type-A receptor 4 isoform 1 (human)


apoptosis regulator Bcl-2 isoform 1 phosphorylated 4 (human)


transmembrane domain-containing protein TMIGD3 isoform 2 (human)


thymidine kinase 2, mitochondrial, transit peptide removed form (human)


cytotoxic T-lymphocyte protein 4 isoform h1 (human)


oxysterols receptor LXR-alpha isoform h1 (human)


tryptase alpha/beta-1 isoform h2 (human)


lethal(3)malignant brain tumor-like protein 1 isoform h1 (human)


NACHT, LRR and PYD domains-containing protein 3


peroxisomal acyl-coenzyme A oxidase 3 isoform 1 (human)


cyclin-dependent kinase 11B isoform hSV1 (human)


phosphatidylinositol 4-phosphate 5-kinase type-1 alpha isoform h2 (human)


proto-oncogene tyrosine-protein kinase receptor Ret isoform 2 (human)


exopolyphosphatase PRUNE1 isoform h4 (human)


tumor necrosis factor receptor superfamily member 8


sodium channel protein type 5 subunit alpha isoform h4 (human)


T-lymphocyte activation antigen CD80 isoform h1 (human)


phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2


amiloride-sensitive sodium channel subunit alpha isoform h2 (human)


antithrombin-III O-glycosylated 1 (human)


retinoic acid receptor RXR-gamma isoform 1 (mouse)


von Willebrand factor O-glycosylated 9 (human)


microtubule-associated protein tau sequence variant A152T (human)


beta-adrenergic receptor kinase 1, initiator methionine removed form (human)


sodium- and chloride-dependent GABA transporter 2 isoform h2 (human)


MHC class I histocompatibility antigen A alpha chain


glutamate receptor ionotropic, kainate 4 isoform 1 (human)


amyloid-beta precursor protein sequence variant E246K (human)


voltage-dependent P/Q-type calcium channel subunit alpha-1A isoform h4 (human)


glucocorticoid receptor isoform Alpha-B (human)


cholinesterase, signal peptide removed form (human)


major prion protein N-glycosylated 17 (mouse)


protein-L-isoaspartate(D-aspartate) O-methyltransferase isoform h2 (human)


myosin light chain kinase, smooth muscle isoform hDel-1790 (human)


epidermal growth factor receptor, signal peptide removed phosphorylated 1 (human)


phosphatidylinositol 5-phosphate 4-kinase type-2 beta isoform 1 (human)


transient receptor potential cation channel TRPV1


fibroblast growth factor receptor 1 isoform 1 (human)


interleukin-1 receptor-associated kinase 1 phosphorylated 5 (human)


thioredoxin reductase 1, cytoplasmic isoform h6 (human)


solute carrier family 2, facilitated glucose transporter member 4 isoform 1 (rat)


androgen receptor isoform 1 acetylated 1 (human)


tyrosine-protein kinase receptor UFO, signal peptide removed phosphorylated 1 (human)


tumor necrosis factor receptor superfamily member 8 isoform h3 (human)


mineralocorticoid receptor isoform r3 (rat)


sodium channel subunit beta-1, signal peptide removed form (human)


G protein-coupled receptor kinase 4 isoform h4 (human)


protein kinase C theta type phosphorylated 4 (human)


mitogen-activated protein kinase kinase kinase 7 phosphorylated 2 (human)


placenta growth factor isoform hPlGF-1 (human)


3-phosphoinositide-dependent protein kinase 1 isoform h2 (human)


neuronal acetylcholine receptor subunit beta-4


gamma-aminobutyric acid type B receptor subunit 2 isoform 1 (rat)


tissue-type plasminogen activator N-glycosylated 3 (human)


retinoic acid receptor RXR-alpha isoform 1 (mouse)


17-beta-hydroxysteroid dehydrogenase type 3


gamma-butyrobetaine dioxygenase isoform 1 (human)


potassium voltage-gated channel subfamily KQT member 2 isoform 9 (mouse)


dual specificity mitogen-activated protein kinase kinase 7 phosphorylated 1 (human)


tissue-type plasminogen activator N-glycosylated 111 (human)


HLA class I histocompatibility antigen, A-25 alpha chain (human)


sodium- and chloride-dependent glycine transporter 1 isoform hGlyT-1B (human)


interstitial collagenase N-glycosylated 22 (human)


dual specificity mitogen-activated protein kinase kinase 1


prolyl endopeptidase FAP isoform m1 (mouse)


transient receptor potential cation channel subfamily M member 5 isoform h1 (human)


endothelial PAS domain-containing protein 1


aspartate--tRNA ligase, cytoplasmic isoform 1 (human)


interleukin-4 receptor subunit alpha isoform h1 (human)


mitogen-activated protein kinase kinase kinase kinase 4 isoform h2 (human)


growth factor receptor-bound protein 2 isoform 1 (mouse)


ATP synthase subunit alpha, mitochondrial


amiloride-sensitive amine oxidase [copper-containing], signal peptide removed form (human)


calcium/calmodulin-dependent protein kinase type II subunit gamma


T-cell surface glycoprotein CD3 epsilon chain isoform 1 (human)


serine/threonine-protein kinase B-raf isoform m1 phosphorylated 5 (mouse)


cyclin-dependent kinase 13 isoform h2 (human)


tissue-type plasminogen activator N-glycosylated 105 (human)


eukaryotic translation initiation factor 4E, initiator methionine removed form (human)


glutamate carboxypeptidase 2 isoform hPSMA-8 (human)


glutamate receptor ionotropic, kainate 1 isoform rGlur5-2A (rat)


gastric inhibitory polypeptide receptor isoform h2 (human)


dual specificity mitogen-activated protein kinase kinase 6 isoform h2 (human)


prokaryote-type phenylalanine--tRNA ligase alpha subunit


UDP-glucuronosyltransferase 1A10 isoform h1 (human)


glutamate receptor ionotropic, NMDA 1 N-glycosylated 3 (rat)


D(2) dopamine receptor isoform 1 (mouse)


immunoglobulin heavy constant gamma 2 N-glycosylated 17 (human)


serine/threonine-protein kinase 4 isoform h2 (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform hPDE4C5 (human)


5'-AMP-activated protein kinase catalytic subunit alpha-2 phosphorylated 1 (human)


amyloid-beta precursor protein sequence variant I716M (human)


receptor-interacting serine/threonine-protein kinase 1


alpha-1-acid glycoprotein 1 N-glycosylated 36 (human)


DNA (cytosine-5)-methyltransferase 3B isoform h1 (human)


peptidyl-prolyl cis-trans isomerase FKBP10 isoform h2 (human)


glutamate receptor ionotropic, kainate 5


histone deacetylase 7 isoform h7 (human)


sex hormone-binding globulin isoform 2 (human)


serine/threonine-protein kinase TBK1 phosphorylated 1 (human)


voltage-dependent T-type calcium channel subunit alpha-1I isoform h3 (human)


ephrin type-B receptor 3, signal peptide removed phosphorylated 1 (human)


integrin beta-2 phosphorylated 1 (human)


fibroblast growth factor receptor 1 isoform 1, signal peptide removed form (human)


cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A


sphingosine 1-phosphate receptor 5 isoform h2 (human)


gamma-aminobutyric acid type B receptor subunit 1 isoform r1E (rat)


GAF-containing cyclic nucleotide-dependent 3',5'-cyclic phosphodiesterase


peroxisome proliferator-activated receptor gamma phosphorylated 1 (mouse)


MHC class I histocompatibility antigen alpha chain


aminopeptidase N O-glycosylated 1 (human)


non-receptor tyrosine-protein kinase TNK1 isoform h1 (human)


activin receptor type-1B, signal peptide removed form (human)


coagulation factor X N-glycosylated 22 (human)


prostaglandin-H2 D-isomerase N-glycosylated 20 (human)


estrogen receptor beta isoform 7 (human)


transcription factor p65 isoform h2 (human)


microtubule-associated protein tau sequence variant I360V (human)


serine/threonine-protein kinase PLK1 phosphorylated 1 (human)


prostate-specific antigen N-glycosylated 18 (human)


beta-hexosaminidase subunit beta N-glycosylated 12 (human)


inhibitor of nuclear factor kappa-B kinase subunit alpha


interstitial collagenase, signal peptide removed form (human)


5-hydroxytryptamine receptor 3C, signal peptide removed form (human)


mitogen-activated protein kinase kinase kinase kinase 4, initiator methionine removed form (human)


mitogen-activated protein kinase kinase kinase 15 isoform h3 (human)


potassium voltage-gated channel subfamily KQT member 2 isoform m13 (mouse)


carnitine O-palmitoyltransferase 1, liver isoform isoform 1 (rat)


nuclear receptor subfamily 1 group I member 3 isoform h9 (human)


ephrin type-A receptor 8, signal peptide removed phosphorylated 1 (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant L342F (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform h4 (human)


gamma-aminobutyric acid receptor subunit alpha-2 isoform 1 (human)


cGMP-dependent 3',5'-cyclic phosphodiesterase isoform rPDE2A2 (rat)


voltage-dependent T-type calcium channel subunit alpha-1G isoform h14 (human)


E3 ubiquitin-protein ligase Mdm2 isoform hMdm2-D (human)


sodium/glucose cotransporter 5 isoform h4 (human)


tyrosine-protein kinase receptor Tie-1 isoform h1 (human)


renin isoform 1, signal peptide removed form (rat)


endoplasmic reticulum aminopeptidase 1 isoform h1 (human)


procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, signal peptide removed form (human)


BMP receptor type-2 sequence variant C483R (human)


serine/threonine-protein kinase Nek6 phosphorylated 1 (human)


mitogen-activated protein kinase kinase kinase 15


prostate-specific antigen N-glycosylated 34 (human)


amyloid-beta precursor protein isoform L-APP752 (human)


immunoglobulin heavy constant gamma 4 N-glycosylated 22 (human)


tyrosine-protein kinase Lck isoform h3 (human)


metabotropic glutamate receptor 7, signal peptide removed form (human)


sodium channel protein type 3 subunit alpha isoform 1 (rat)


voltage-dependent calcium channel subunit alpha-2/delta-2 isoform h5 (human)


matrix metalloproteinase-14 phosphorylated 1 (human)


coagulation factor IX isoform h1 (human)


von Willebrand factor N-glycosylated 13 (human)


peptidyl-prolyl cis-trans isomerase FKBP1B


eukaryotic translation initiation factor 2-alpha kinase 1 isoform h2 (human)


E3 ubiquitin-protein ligase Mdm2 phosphorylated 4 (human)


tumor necrosis factor ligand superfamily member 10/11


histone deacetylase 3 isoform 1 unphosphorylated 1 (human)


5-aminolevulinate synthase, non-specific, mitochondrial


E9Q9V9_MOUSE Retinoic acid receptor RXR-gamma (trembl)


NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial isoform h2 (human)


endothelin-1 receptor, signal peptide removed form (human)


voltage-dependent T-type calcium channel subunit alpha-1G isoform h6 (human)


plasma kallikrein, signal peptide removed form (human)


TRAF2 and NCK-interacting protein kinase isoform h3 (human)


kappa-type opioid receptor isoform 1 (human)


prostate-specific antigen N-glycosylated 66 (human)


3-hydroxy-3-methylglutaryl-coenzyme A reductase isoform h1 (human)


dual specificity protein phosphatase 6 isoform 1 (rat)


high affinity nerve growth factor receptor isoform TrkA-I mature form N-glycosylated and phosphorylated 2 (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform r31 (rat)


voltage-dependent L-type calcium channel subunit alpha-1D isoform Beta-cell-type (human)


lutropin-choriogonadotropic hormone receptor isoform rB3 (rat)


sodium- and chloride-dependent GABA transporter 2 isoform 1 (rat)


cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B isoform h1 (human)


nitric oxide synthase, brain isoform h3 (human)


microtubule-associated protein tau isoform Tau-F phosphorylated form (human)


peroxisome proliferator-activated receptor alpha isoform 1 (human)


integrin alpha-IIb O-glycosylated 2 (human)


sigma non-opioid intracellular receptor 1 isoform 1 (rat)


mast/stem cell growth factor receptor Kit isoform m2 phosphorylated 2 (mouse)


sulfide:quinone oxidoreductase, mitochondrial isoform 1 (human)


sodium-dependent neutral amino acid transporter B(0)AT1


non-receptor tyrosine-protein kinase TNK1 isoform h2 (human)


nuclear receptor ROR-alpha isoform h4 (human)


matrix metalloproteinase-14 isoform 1 (human)


macrophage-stimulating protein receptor isoform Delta-RON (human)


voltage-dependent L-type calcium channel subunit alpha-1C isoform r5 (rat)


sodium/glucose cotransporter 4 isoform h3 (human)


retinol-binding protein 3, signal peptide removed form (human)


amiloride-sensitive sodium channel subunit beta


casein kinase I isoform gamma-3 isoform h3 (human)


multidrug resistance-associated protein 1 isoform h9 (human)


transient receptor potential cation channel subfamily V member 1 isoform m2 (mouse)


ribosomal protein S6 kinase alpha-4 phosphorylated 1 (human)


deoxyguanosine kinase, mitochondrial isoform 1 (human)


interleukin-17 receptor C isoform h5 (human)


cytosolic purine 5'-nucleotidase isoform h2 (human)


growth factor receptor-bound protein 2 isoform 2 (human)


DNA topoisomerase I, mitochondrial isoform h1 (human)


amiloride-sensitive sodium channel subunit alpha


major prion protein N-glycosylated 35 (mouse)


gamma-aminobutyric acid receptor subunit gamma-2 isoform h3 (human)


72 kDa type IV collagenase isoform 2 (human)


NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11, initiator methionine removed form (human)


gamma-aminobutyric acid receptor subunit beta-2 isoform h3 (human)


NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial isoform h3 (human)


activated CDC42 kinase 1 phosphorylated 1 (human)


NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial


alpha-1-acid glycoprotein 1 N-glycosylated 55 (human)


phosphatidylinositol 5-phosphate 4-kinase type-2 alpha


tyrosine-protein kinase ABL1 isoform 2 (human)


transitional endoplasmic reticulum ATPase isoform 1 (human)


activin receptor type-1 isoform 1 (human)


serine/threonine-protein kinase 36 isoform h2 (human)


sodium/glucose cotransporter 2 O-glycosylated 1 (human)


immunoglobulin heavy constant gamma 3 N-glycosylated 2 (human)


vitamin K epoxide reductase complex subunit 1


5-hydroxytryptamine receptor 1A isoform 1 (human)


pancreatic triacylglycerol lipase, signal peptide removed form (human)


solute carrier family 2, facilitated glucose transporter member 2


protein arginine N-methyltransferase 1 isoform V1 (human)


glycogen synthase kinase-3 beta phosphorylated 2 (human)


follicle-stimulating hormone receptor isoform Short (human)


gamma-aminobutyric acid receptor subunit gamma-2 isoform 1 (rat)


cytokine receptor common subunit beta isoform 1 (human)


ephrin type-A receptor 2 isoform h2 (human)


transferrin receptor protein 1 O-glycosylated 1 (human)


ribosomal protein S6 kinase alpha-6 isoform h1 (human)


cAMP-dependent protein kinase catalytic subunit beta isoform h7 (human)


serine/threonine-protein kinase Nek7 isoform h2 (human)


mu-type opioid receptor isoform r6 (rat)


vascular endothelial growth factor A isoform hVEGF111 (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant T311I (human)


serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform h1 (human)


tumor-associated calcium signal transducer 2 phosphorylated 1 (human)


transient receptor potential cation channel TRPC with PDZ-binding motif


fibroblast growth factor receptor 3 isoform h3 (human)


immunoglobulin heavy constant gamma 4 N-glycosylated 33 (human)


mast/stem cell growth factor receptor Kit isoform m3 (mouse)


prostate-specific antigen N-glycosylated 39 (human)


phosphoethanolamine/phosphocholine phosphatase isoform h2 (human)


serine/threonine-protein kinase PAK 3 isoform 1 (human)


major prion protein N-glycosylated 29 (mouse)


transient receptor potential cation channel subfamily M member 4


DNA (cytosine-5)-methyltransferase 1 isoform h3 (human)


prostatic acid phosphatase N-glycosylated 10 (human)


sodium channel protein type 3 subunit alpha isoform 4 (human)


vascular endothelial growth factor receptor 2 N-glycosylated 18 (mouse)


tyrosine-protein phosphatase non-receptor type 7 isoform h1 (human)


cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform 3 (rat)


1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform 1 (rat)


prostatic acid phosphatase, signal peptide removed form (human)


sodium/potassium-transporting ATPase subunit alpha-1 isoform 1 (human)


fibroblast growth factor receptor 1 isoform h7 (human)


voltage-gated potassium channel subunit KCNQ1 sequence variant G589D (human)


D(2) dopamine receptor isoform Short (rat)


1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, transit peptide removed form (human)


NACHT, LRR and PYD domains-containing protein 3 isoform m4 (mouse)


lysine-specific histone demethylase 2 isoform h4 (human)


sex hormone-binding globulin N-glycosylated 13 (human)


methionine aminopeptidase 2 isoform h2 (human)


vitamin K-dependent protein C N-glycosylated 22 (human)


mu-type opioid receptor isoform r3 (rat)


voltage-dependent L-type calcium channel subunit alpha-1C isoform h35 (human)


immunoglobulin heavy constant epsilon N-glycosylated 3 (human)


ADP/ATP translocase 1, initiator methionine removed form (human)


estrogen-related receptor gamma isoform 2 (human)


TGF-beta receptor type-1, signal peptide removed form (human)


myeloid cell surface antigen CD33 O-glycosylated 1 (human)


1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, initiator methionine removed phosphorylated 3 (human)


cation channel sperm-associated protein 2 isoform 2 (human)


histone-lysine N-methyltransferase EHMT1 isoform h3 (human)


dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C


proteasome subunit beta type-8 isoform 1 (human)


von Willebrand factor, signal peptide removed form (human)


MAP/microtubule affinity-regulating kinase 3 isoform h6 (human)


sodium channel protein type 10 subunit alpha isoform r2 (rat)


MAP kinase-activated protein kinase 5 phosphorylated 2 (human)


5'-AMP-activated protein kinase subunit beta-1, initiator methionine removed form (human)


MAP/microtubule affinity-regulating kinase 3


DNA-dependent protein kinase catalytic subunit


receptor-interacting serine/threonine-protein kinase 3 isoform h3 (human)


poly [ADP-ribose] polymerase tankyrase-1


cyclin-dependent kinase 11B isoform h8 (human)


chloride channel protein ClC-Kb isoform h1 (human)


aspartate aminotransferase, mitochondrial isoform h2 (human)


sodium channel protein type 9 subunit alpha isoform h2 (human)


protein kinase C beta type, initiator methionine removed form (human)


metabotropic glutamate receptor 3 N-glycosylated 1 (rat)


tyrosine-protein kinase FRK isoform h1 (human)


poly [ADP-ribose] polymerase tankyrase-1 isoform h2 (human)


microtubule-associated protein tau sequence variant V75A (human)


dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform h3 (human)


solute carrier family 22 member 6 isoform h3 (human)


metabotropic glutamate receptor 3 N-glycosylated 3 (rat)


D(2) dopamine receptor isoform 2 (human)


prokaryote-type phenylalanine--tRNA ligase beta subunit


histone deacetylase 9 isoform h2 (human)


microtubule-associated protein tau sequence variant R370W (human)


coagulation factor X O-glycosylated 4 (human)


amyloid-beta precursor protein sequence variant A235V (human)


ATP-dependent translocase ABCB1 isoform h2 (human)


coagulation factor XI N-glycosylated 4 (human)


vitamin K-dependent protein C N-glycosylated 26 (human)


sex hormone-binding globulin isoform, signal peptide removed glycosylated 9 (human)


von Willebrand factor N-glycosylated 4 (human)


DNA (cytosine-5)-methyltransferase 1 phosphorylated 1 (human)


serine hydroxymethyltransferase, cytosolic isoform h2 (human)


5-hydroxytryptamine receptor 4 isoform h5-HT4(D) (human)


endoplasmic reticulum chaperone BiP, signal peptide removed form (human)


kappa-type opioid receptor phosphorylated 3 (mouse)


insulin-degrading enzyme ubiquitinated form (human)


neuronal acetylcholine receptor subunit beta-3, signal peptide removed form (human)


major prion protein N-glycosylated 6 (mouse)


peptidyl-prolyl cis-trans isomerase FKBP1B isoform h2 (human)


phosphatidylinositol 5-phosphate 4-kinase type-2 gamma


prostate-specific antigen isoform h3 (human)


calcium/calmodulin-dependent protein kinase type II subunit gamma isoform h11 (human)


cGMP-gated cation channel alpha-1 sequence variant S320F (human)


dual specificity mitogen-activated protein kinase kinase 4 isoform h1 (human)